Review



oncoscan cna arrays  (Thermo Fisher)


Bioz Verified Symbol Thermo Fisher is a verified supplier
Bioz Manufacturer Symbol Thermo Fisher manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Thermo Fisher oncoscan cna arrays
    OSCHP plots by Affymetrix <t>OncoScan</t> for whole‐genome <t>CNA.</t> (A) Genomic copy number gain and loss for chromosomes 1 to 22 and X were obtained in nine cases, with LM‐BN regions presented above and LMS regions below. Arrows indicate CNA shared by LM‐BN and LMS, indicating clonality. (Case 1 LM‐BN was tetraploid. A circular dot in case 2 indicates STUMP component.) (B, C) Dot plots represented the number of detectable sites of (B) CNA gain and (C) loss in genomic regions from nine cases. (D) Dot plots for LOH in LM‐BN and LMS. (E, F) Fraction of genome alteration in LMS and LM‐BN regions (E) individually and (F) combined analysis of fraction of genome alteration in LMS and LM‐BN. * p <0.05; ** p <0.01; *** p < 0.001; ns = no statistical significance.
    Oncoscan Cna Arrays, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/oncoscan+array/pmc11717496-99-4-8
    Average 90 stars, based on 1 article reviews
    oncoscan cna arrays - by Bioz Stars, 2026-10
    90/100 stars

    Images

    1) Product Images from "Genomic characterization and histologic analysis of uterine leiomyosarcoma arising from leiomyoma with bizarre nuclei"

    Article Title: Genomic characterization and histologic analysis of uterine leiomyosarcoma arising from leiomyoma with bizarre nuclei

    Journal: The Journal of Pathology

    doi: 10.1002/path.6379

    OSCHP plots by Affymetrix OncoScan for whole‐genome CNA. (A) Genomic copy number gain and loss for chromosomes 1 to 22 and X were obtained in nine cases, with LM‐BN regions presented above and LMS regions below. Arrows indicate CNA shared by LM‐BN and LMS, indicating clonality. (Case 1 LM‐BN was tetraploid. A circular dot in case 2 indicates STUMP component.) (B, C) Dot plots represented the number of detectable sites of (B) CNA gain and (C) loss in genomic regions from nine cases. (D) Dot plots for LOH in LM‐BN and LMS. (E, F) Fraction of genome alteration in LMS and LM‐BN regions (E) individually and (F) combined analysis of fraction of genome alteration in LMS and LM‐BN. * p <0.05; ** p <0.01; *** p < 0.001; ns = no statistical significance.
    Figure Legend Snippet: OSCHP plots by Affymetrix OncoScan for whole‐genome CNA. (A) Genomic copy number gain and loss for chromosomes 1 to 22 and X were obtained in nine cases, with LM‐BN regions presented above and LMS regions below. Arrows indicate CNA shared by LM‐BN and LMS, indicating clonality. (Case 1 LM‐BN was tetraploid. A circular dot in case 2 indicates STUMP component.) (B, C) Dot plots represented the number of detectable sites of (B) CNA gain and (C) loss in genomic regions from nine cases. (D) Dot plots for LOH in LM‐BN and LMS. (E, F) Fraction of genome alteration in LMS and LM‐BN regions (E) individually and (F) combined analysis of fraction of genome alteration in LMS and LM‐BN. * p <0.05; ** p <0.01; *** p < 0.001; ns = no statistical significance.

    Techniques Used:

    Related Articles

    other:

    Article Title: Genomic characterization and histologic analysis of uterine leiomyosarcoma arising from leiomyoma with bizarre nuclei
    Article Snippet: DNA was analyzed using Affymetrix OncoScan CNA arrays (Thermo Fisher Scientific, Santa Clara, CA, USA).



    Similar Products

    90
    Thermo Fisher oncoscan snp array
    Oncoscan Snp Array, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/oncoscan+array/10__5858_slash_arpa__2024___0267___oa-58-6-22
    Average 90 stars, based on 1 article reviews
    oncoscan snp array - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Fisher Scientific comparative genomic hybridization array cgha oncoscan ffpe assays kits
    Comparative Genomic Hybridization Array Cgha Oncoscan Ffpe Assays Kits, supplied by Fisher Scientific, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/oncoscan+array/comparative+genomic+hybridization+array+cgha+oncoscan+ffpe+assays+kits/pm40506517-84-6-19
    Average 90 stars, based on 1 article reviews
    comparative genomic hybridization array cgha oncoscan ffpe assays kits - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher cytoscan hd/oncoscan array
    Cytoscan Hd/Oncoscan Array, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/oncoscan+array/cytoscan+hd+array/pmc11798607-147-0-3
    Average 90 stars, based on 1 article reviews
    cytoscan hd/oncoscan array - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher oncoscan cna arrays
    OSCHP plots by Affymetrix <t>OncoScan</t> for whole‐genome <t>CNA.</t> (A) Genomic copy number gain and loss for chromosomes 1 to 22 and X were obtained in nine cases, with LM‐BN regions presented above and LMS regions below. Arrows indicate CNA shared by LM‐BN and LMS, indicating clonality. (Case 1 LM‐BN was tetraploid. A circular dot in case 2 indicates STUMP component.) (B, C) Dot plots represented the number of detectable sites of (B) CNA gain and (C) loss in genomic regions from nine cases. (D) Dot plots for LOH in LM‐BN and LMS. (E, F) Fraction of genome alteration in LMS and LM‐BN regions (E) individually and (F) combined analysis of fraction of genome alteration in LMS and LM‐BN. * p <0.05; ** p <0.01; *** p < 0.001; ns = no statistical significance.
    Oncoscan Cna Arrays, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/oncoscan+array/pmc11717496-99-4-8
    Average 90 stars, based on 1 article reviews
    oncoscan cna arrays - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher oncoscan cnv plus array
    OSCHP plots by Affymetrix <t>OncoScan</t> for whole‐genome <t>CNA.</t> (A) Genomic copy number gain and loss for chromosomes 1 to 22 and X were obtained in nine cases, with LM‐BN regions presented above and LMS regions below. Arrows indicate CNA shared by LM‐BN and LMS, indicating clonality. (Case 1 LM‐BN was tetraploid. A circular dot in case 2 indicates STUMP component.) (B, C) Dot plots represented the number of detectable sites of (B) CNA gain and (C) loss in genomic regions from nine cases. (D) Dot plots for LOH in LM‐BN and LMS. (E, F) Fraction of genome alteration in LMS and LM‐BN regions (E) individually and (F) combined analysis of fraction of genome alteration in LMS and LM‐BN. * p <0.05; ** p <0.01; *** p < 0.001; ns = no statistical significance.
    Oncoscan Cnv Plus Array, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/oncoscan+array/oncoscan+ffpe+assay+kit/pm39692003-39-14-18
    Average 90 stars, based on 1 article reviews
    oncoscan cnv plus array - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher oncoscan cnv plus arrays
    OSCHP plots by Affymetrix <t>OncoScan</t> for whole‐genome <t>CNA.</t> (A) Genomic copy number gain and loss for chromosomes 1 to 22 and X were obtained in nine cases, with LM‐BN regions presented above and LMS regions below. Arrows indicate CNA shared by LM‐BN and LMS, indicating clonality. (Case 1 LM‐BN was tetraploid. A circular dot in case 2 indicates STUMP component.) (B, C) Dot plots represented the number of detectable sites of (B) CNA gain and (C) loss in genomic regions from nine cases. (D) Dot plots for LOH in LM‐BN and LMS. (E, F) Fraction of genome alteration in LMS and LM‐BN regions (E) individually and (F) combined analysis of fraction of genome alteration in LMS and LM‐BN. * p <0.05; ** p <0.01; *** p < 0.001; ns = no statistical significance.
    Oncoscan Cnv Plus Arrays, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/oncoscan+array/oncoscan+ffpe+assay+kit/pm39554783-47-10-14
    Average 90 stars, based on 1 article reviews
    oncoscan cnv plus arrays - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher inversion probe array oncoscan copy number variation assay
    OSCHP plots by Affymetrix <t>OncoScan</t> for whole‐genome <t>CNA.</t> (A) Genomic copy number gain and loss for chromosomes 1 to 22 and X were obtained in nine cases, with LM‐BN regions presented above and LMS regions below. Arrows indicate CNA shared by LM‐BN and LMS, indicating clonality. (Case 1 LM‐BN was tetraploid. A circular dot in case 2 indicates STUMP component.) (B, C) Dot plots represented the number of detectable sites of (B) CNA gain and (C) loss in genomic regions from nine cases. (D) Dot plots for LOH in LM‐BN and LMS. (E, F) Fraction of genome alteration in LMS and LM‐BN regions (E) individually and (F) combined analysis of fraction of genome alteration in LMS and LM‐BN. * p <0.05; ** p <0.01; *** p < 0.001; ns = no statistical significance.
    Inversion Probe Array Oncoscan Copy Number Variation Assay, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/oncoscan+array/inversion+probe+array+oncoscan+copy+number+variation+assay/pmc11576554-31-10-19
    Average 90 stars, based on 1 article reviews
    inversion probe array oncoscan copy number variation assay - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher oncoscan array data (oschp les
    OSCHP plots by Affymetrix <t>OncoScan</t> for whole‐genome <t>CNA.</t> (A) Genomic copy number gain and loss for chromosomes 1 to 22 and X were obtained in nine cases, with LM‐BN regions presented above and LMS regions below. Arrows indicate CNA shared by LM‐BN and LMS, indicating clonality. (Case 1 LM‐BN was tetraploid. A circular dot in case 2 indicates STUMP component.) (B, C) Dot plots represented the number of detectable sites of (B) CNA gain and (C) loss in genomic regions from nine cases. (D) Dot plots for LOH in LM‐BN and LMS. (E, F) Fraction of genome alteration in LMS and LM‐BN regions (E) individually and (F) combined analysis of fraction of genome alteration in LMS and LM‐BN. * p <0.05; ** p <0.01; *** p < 0.001; ns = no statistical significance.
    Oncoscan Array Data (Oschp Les, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/oncoscan+array/ppr0926610-113-18-33
    Average 90 stars, based on 1 article reviews
    oncoscan array data (oschp les - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher oncoscan® ffpe snp-array kit
    OSCHP plots by Affymetrix <t>OncoScan</t> for whole‐genome <t>CNA.</t> (A) Genomic copy number gain and loss for chromosomes 1 to 22 and X were obtained in nine cases, with LM‐BN regions presented above and LMS regions below. Arrows indicate CNA shared by LM‐BN and LMS, indicating clonality. (Case 1 LM‐BN was tetraploid. A circular dot in case 2 indicates STUMP component.) (B, C) Dot plots represented the number of detectable sites of (B) CNA gain and (C) loss in genomic regions from nine cases. (D) Dot plots for LOH in LM‐BN and LMS. (E, F) Fraction of genome alteration in LMS and LM‐BN regions (E) individually and (F) combined analysis of fraction of genome alteration in LMS and LM‐BN. * p <0.05; ** p <0.01; *** p < 0.001; ns = no statistical significance.
    Oncoscan® Ffpe Snp Array Kit, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/oncoscan+array/pm39215000-353-6-11
    Average 90 stars, based on 1 article reviews
    oncoscan® ffpe snp-array kit - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    Image Search Results


    OSCHP plots by Affymetrix OncoScan for whole‐genome CNA. (A) Genomic copy number gain and loss for chromosomes 1 to 22 and X were obtained in nine cases, with LM‐BN regions presented above and LMS regions below. Arrows indicate CNA shared by LM‐BN and LMS, indicating clonality. (Case 1 LM‐BN was tetraploid. A circular dot in case 2 indicates STUMP component.) (B, C) Dot plots represented the number of detectable sites of (B) CNA gain and (C) loss in genomic regions from nine cases. (D) Dot plots for LOH in LM‐BN and LMS. (E, F) Fraction of genome alteration in LMS and LM‐BN regions (E) individually and (F) combined analysis of fraction of genome alteration in LMS and LM‐BN. * p <0.05; ** p <0.01; *** p < 0.001; ns = no statistical significance.

    Journal: The Journal of Pathology

    Article Title: Genomic characterization and histologic analysis of uterine leiomyosarcoma arising from leiomyoma with bizarre nuclei

    doi: 10.1002/path.6379

    Figure Lengend Snippet: OSCHP plots by Affymetrix OncoScan for whole‐genome CNA. (A) Genomic copy number gain and loss for chromosomes 1 to 22 and X were obtained in nine cases, with LM‐BN regions presented above and LMS regions below. Arrows indicate CNA shared by LM‐BN and LMS, indicating clonality. (Case 1 LM‐BN was tetraploid. A circular dot in case 2 indicates STUMP component.) (B, C) Dot plots represented the number of detectable sites of (B) CNA gain and (C) loss in genomic regions from nine cases. (D) Dot plots for LOH in LM‐BN and LMS. (E, F) Fraction of genome alteration in LMS and LM‐BN regions (E) individually and (F) combined analysis of fraction of genome alteration in LMS and LM‐BN. * p <0.05; ** p <0.01; *** p < 0.001; ns = no statistical significance.

    Article Snippet: DNA was analyzed using Affymetrix OncoScan CNA arrays (Thermo Fisher Scientific, Santa Clara, CA, USA).

    Techniques: